A week in tech

A summary of all the major tech stories in Asia this week broken down by country and sector.

A week in Japanese tech

Life Sciences

- Eli Lilly is to market new osteoporosis drug for Japan. Eli Lilly Japan has applied to the Health Ministry for permission to market raloxifene HCl for the treatment of osteoporosis in post-menopausal women. Eli Lilly is developing the Japanese market to compensate for the loss in revenues associated with the expiration of its patent on Prozac.

- Takeda Chemical Industries is to overhaul drug RD processes. The top-ranked pharmaceutical manufacturer will...

To continue reading, please login or register for free

Click for more on: week | tech

Print Edition

FinanceAsia Print Edition